Angiotensin II increases collagen I expression via transforming growth factor-beta1 and extracellular signal-regulated kinase in cardiac fibroblasts
- PMID: 19374881
- DOI: 10.1016/j.ejphar.2008.12.049
Angiotensin II increases collagen I expression via transforming growth factor-beta1 and extracellular signal-regulated kinase in cardiac fibroblasts
Abstract
Angiotensin II is a powerful mediator to induce cardiac remodeling and fibrosis. Transforming growth factor-beta1 (TGF-beta1) and extracellular signal-regulated kinase (ERK) have been implicated in the angiotensin II-induced cardiac fibrosis. However, the signaling pathways for this angiotensin II effect and the interaction between ERK and the TGF-beta1 signaling in this effect have not been well-illustrated. Cardiac fibroblasts were prepared from the ventricles of adult male Sprague-Dawley rats. They were treated with 1 microM angiotensin II in the presence or absence of losartan (angiotensin II AT(1) receptor antagonist), PD123319 (angiotensin II AT(2) receptor antagonist), an anti-TGF-beta1 antibody or PD98059 (ERK inhibitor). The cells were collected for Western blotting and reverse transcription-polymerase chain reaction. Angiotensin II caused a significant increase of the expression of TGF-beta(1), ERK1, phosphorylated-Smad2/3, Smad4 and collagen I. This increase was attenuated by losartan but was not affected by PD123319. An anti-TGF-beta(1) antibody and PD98059 diminished angiotensin II-induced Smad2/3 phosphorylation and the expression of Smad7 and collagen I. Our results suggest that angiotensin II induces collagen I expression through angiotensin II AT(1) receptor-TGF-beta(1)-Smads signaling pathway in cardiac fibroblasts. ERK, by regulating Smads signaling, also participated in the angiotensin II-induced collagen I expression.
Similar articles
-
Hypoxia regulates basal and induced DNA synthesis and collagen type I production in human cardiac fibroblasts: effects of transforming growth factor-beta1, thyroid hormone, angiotensin II and basic fibroblast growth factor.J Mol Cell Cardiol. 1997 Aug;29(8):2233-44. doi: 10.1006/jmcc.1997.0462. J Mol Cell Cardiol. 1997. PMID: 9281454
-
Angiotensin II activates connective tissue growth factor and induces extracellular matrix changes involving Smad/activation and p38 mitogen-activated protein kinase signalling pathways in human dermal fibroblasts.Exp Dermatol. 2009 Nov;18(11):947-53. doi: 10.1111/j.1600-0625.2009.00880.x. Epub 2009 Apr 24. Exp Dermatol. 2009. PMID: 19397700
-
Angiotensin II increases CTGF expression via MAPKs/TGF-β1/TRAF6 pathway in atrial fibroblasts.Exp Cell Res. 2012 Oct 1;318(16):2105-15. doi: 10.1016/j.yexcr.2012.06.015. Epub 2012 Jun 27. Exp Cell Res. 2012. PMID: 22749815
-
TGF-beta1 and angiotensin networking in cardiac remodeling.Cardiovasc Res. 2004 Aug 15;63(3):423-32. doi: 10.1016/j.cardiores.2004.04.030. Cardiovasc Res. 2004. PMID: 15276467 Review.
-
Induction of cardiac fibrosis by transforming growth factor-beta(1).Mol Genet Metab. 2000 Sep-Oct;71(1-2):418-35. doi: 10.1006/mgme.2000.3032. Mol Genet Metab. 2000. PMID: 11001836 Review.
Cited by
-
The angiotensin receptor blocker losartan reduces coronary arteriole remodeling in type 2 diabetic mice.Vascul Pharmacol. 2016 Jan;76:28-36. doi: 10.1016/j.vph.2015.06.013. Epub 2015 Jun 30. Vascul Pharmacol. 2016. PMID: 26133668 Free PMC article.
-
At the Intersection of Cardiology and Oncology: TGFβ as a Clinically Translatable Therapy for TNBC Treatment and as a Major Regulator of Post-Chemotherapy Cardiomyopathy.Cancers (Basel). 2022 Mar 19;14(6):1577. doi: 10.3390/cancers14061577. Cancers (Basel). 2022. PMID: 35326728 Free PMC article. Review.
-
Fibrosis of the diabetic heart: Clinical significance, molecular mechanisms, and therapeutic opportunities.Adv Drug Deliv Rev. 2021 Sep;176:113904. doi: 10.1016/j.addr.2021.113904. Epub 2021 Jul 29. Adv Drug Deliv Rev. 2021. PMID: 34331987 Free PMC article. Review.
-
microRNAs as Biomarkers of Endothelial Dysfunction and Therapeutic Target in the Pathogenesis of Atrial Fibrillation.Int J Mol Sci. 2023 Mar 10;24(6):5307. doi: 10.3390/ijms24065307. Int J Mol Sci. 2023. PMID: 36982382 Free PMC article. Review.
-
Antifibrotic therapies to control cardiac fibrosis.Biomater Res. 2016 May 25;20:13. doi: 10.1186/s40824-016-0060-8. eCollection 2016. Biomater Res. 2016. PMID: 27226899 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous